EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Antibodies to Non‐HLA Antigens and Their Role in Organ Transplant Rejection

Katerina Jaklová, Katerina Vychytilová, Aneta Glosová, Antonij Slavcev

International Journal of Immunogenetics · 2026

DOI: 10.1111/iji.70063 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Immunogenetics, 2026. Verfasst von Katerina Jaklová und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunogenetics, Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic. Hauptthemen laut MEDLINE: Graft Rejection, Organ Transplantation, Antibodies. Die Arbeit nennt 105 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibody‐mediated rejection (AMR) is a serious post‐transplant complication that is associated with a worse prognosis of survival of transplanted organs. The diagnosis of AMR is based on clinical, pathological characteristics and on the detection of antibodies specific to the organ donors’ mismatched human leukocyte antigens (HLA) antigens. Accumulating evidence in recent years however suggests that antibodies against antigens encoded by genes outside the HLA complex can play a role in the development of AMR. Non‐HLA antigens are mostly expressed on the surface of endothelial and epithelial cells but can also be localized intracellularly and released in the bloodstream or lymph in case of cell lysis. Among these are major histocompatibility complex (MHC) Class I‐related chain MICA, MICB, angiotensin II‐R1 receptor (ATR1), collagen, K‐α1 tubulin, cardiac myosin, vimentin and other molecules. Antibodies to non‐HLA antigens can occur before transplantation but may be also produced de novo. The detection of non‐HLA antibodies is carried out using the xMap (Luminex) technology, the so‐called endothelial crossmatch and other techniques; however, these methodologies and interpretation of results have their pitfalls. In this short review, we briefly discuss the recent literature on the clinical role of non‐HLA antibodies in organ transplant rejection and survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft RejectionOrgan TransplantationAntibodiesHumansHLA AntigensHistocompatibility Antigens Class IReceptor, Angiotensin, Type 1

Stichwörter der Autor:innen

Luminexhuman leukocyte antigens (HLA)non‐HLA antibodiesrejection

Substanzen

HLA AntigensHistocompatibility Antigens Class IReceptor, Angiotensin, Type 1Antibodies

Autor:innen und Institutionen

  • Department of Immunogenetics, Institute for Clinical and Experimental Medicine (IKEM), Prague, Czech Republic.

Zitieren

APA

Jaklová, K., Vychytilová, K., Glosová, A., & Slavcev, A. (2026). Antibodies to Non‐HLA Antigens and Their Role in Organ Transplant Rejection. International Journal of Immunogenetics. https://doi.org/10.1111/iji.70063

Vancouver

Jaklová K, Vychytilová K, Glosová A, Slavcev A. Antibodies to Non‐HLA Antigens and Their Role in Organ Transplant Rejection. International Journal of Immunogenetics. 2026. doi:10.1111/iji.70063

BibTeX
@article{Jaklov2026,
  author = {Jaklová, Katerina and Vychytilová, Katerina and Glosová, Aneta and Slavcev, Antonij},
  title = {Antibodies to Non‐HLA Antigens and Their Role in Organ Transplant Rejection},
  journal = {International Journal of Immunogenetics},
  year = {2026},
  doi = {10.1111/iji.70063}
}
Kostenlos starten →